Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: From Leckrone`s mouth

RE: From Leckrone`s mouth

posted on Sep 02, 2006 08:51AM
MMP licensing rates can be expected to increase according to plan as first mover MMP portfolio licensing berths continue to be rapidly captured by global leaders.

``Licensing rates can be expected to increase according to plan`` and ``licensing berths continue to be rapidly captured``.

Sounds good and the future looks bright. If we see a flurry of licensing this month, IMO the B1J3 becomes a side show and icing on the cake.

All the best,

Steve

Share
New Message
Please login to post a reply